Stock LVTX LAVA THERAPEUTICS N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. LAVA Therapeutics N.V.

Equities

LVTX

NL0015000AG6

Market Closed - Nasdaq
Other stock markets
 01:30:00 27/04/2024 am IST 		5-day change 1st Jan Change
2.73 USD +3.41% Intraday chart for LAVA Therapeutics N.V. +0.74% +72.78%
20/03 LAVA Therapeutics N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
20/03 LAVA Therapeutics N.V. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts Price Target on Lava Therapeutics to $6 From $9, Maintains Buy Rating
MT
HC Wainwright Starts Lava Therapeutics at Buy With $9 Price Target
MT
SVB Securities Adjusts Price Target on Lava Therapeutics to $28 From $25, Keeps Outperform Rating
MT
JMP Securities Starts Lava Therapeutics at Market Outperform With $6 Price Target
MT
SVB Securities Adjusts LAVA Therapeutics' Price Target to $25 From $23, Keeps Outperform Rating
MT
SVB Leerink Adjusts Price Target on Lava Therapeutics to $20 from $24, Keeps Outperform Rating
MT
LAVA THERAPEUTICS B : SVB Leerink Adjusts Price Target on LAVA Therapeutics to $24 From $26, Maintains Outperform Rating
MT
LAVA THERAPEUTICS B : JP Morgan Starts Lava Therapeutics at Overweight with $22 Price Target
MT
LAVA THERAPEUTICS B : Jefferies Starts Lava Therapeutics at Buy with $23 Price Target
MT
LAVA THERAPEUTICS B : SVB Leerink Initiates LAVA Therapeutics at Outperform Rating With $26 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LVTX Stock
  4. News LAVA Therapeutics N.V.
  5. Analyst Reco.